NCT07169773

Comparative Study Between Rezum and Tamsulosin

Comparison Between Convective Radiofrequency Water Vapor Thermal Ablation (REZUM) Versus Tamsulosin in Management of Lower Urinary Tract Symptoms in Patients With Benign Prostatic Enlargement

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 94 (actual)
• Sponsor: khaled Abdelsattar Gad Ibrahim · Academic / Other
• Sex: Male
• Age: 50 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

the investigators aimed to compare the efficacy and safety of Rezūm therapy for the management of benign prostatic hyperplasia (BPH) with Tamsulosin.

Detailed description

So far, data from available studies point towards good clinical outcomes with a short-term risk of self-limiting minor complications. Its application has demonstrated clinical effectiveness and possesses specific benefits that distinguish it among other treatments. It is applicable to outpatient setting, is effective in preserving sexual function and is versatile in its ability to treat a variety of prostate gland morphology.

Conditions

• Prostate Hyperplasia

Interventions

Type	Name	Description
DEVICE	Rezum	Rezum procedure in Rezum group
DRUG	Tamsulosin	Tamsulosin were given to Tamsulosin group

Timeline

• Start date: 2022-05-01
• Primary completion: 2023-05-01
• Completion: 2023-06-01
• First posted: 2025-09-12
• Last updated: 2025-09-12

Locations

1 site across 1 country: Egypt